Participants were randomly assigned to receive oral , once-daily finerenone ( @ mg/d , n = @ ; @ mg/d , n = @ ; @ mg/d , n = @ ; @ mg/d , n = @ ; @ mg/d , n = @ ; @ mg/d , n = @ ; and @ mg/d , n = @ ) or matching placebo ( n = @ ) for @ days .